Alterations of eye movement control in neurodegenerative movement disorders

Martin Gorges, Elmar H Pinkhardt, Jan Kassubek, Martin Gorges, Elmar H Pinkhardt, Jan Kassubek

Abstract

The evolution of the fovea centralis, the most central part of the retina and the area of the highest visual accuracy, requires humans to shift their gaze rapidly (saccades) to bring some object of interest within the visual field onto the fovea. In addition, humans are equipped with the ability to rotate the eye ball continuously in a highly predicting manner (smooth pursuit) to hold a moving target steadily upon the retina. The functional deficits in neurodegenerative movement disorders (e.g., Parkinsonian syndromes) involve the basal ganglia that are critical in all aspects of movement control. Moreover, neocortical structures, the cerebellum, and the midbrain may become affected by the pathological process. A broad spectrum of eye movement alterations may result, comprising smooth pursuit disturbance (e.g., interrupting saccades), saccadic dysfunction (e.g., hypometric saccades), and abnormal attempted fixation (e.g., pathological nystagmus and square wave jerks). On clinical grounds, videooculography is a sensitive noninvasive in vivo technique to classify oculomotion function alterations. Eye movements are a valuable window into the integrity of central nervous system structures and their changes in defined neurodegenerative conditions, that is, the oculomotor nuclei in the brainstem together with their directly activating supranuclear centers and the basal ganglia as well as cortical areas of higher cognitive control of attention.

Figures

Figure 1
Figure 1
Illustration of cognitive demanding oculomotor tasks in order to assess attentional control. (a) In delayed saccades, subjects are asked to fixate the spot (I) and to withhold their gaze shift towards a new randomly appearing target (II) until an acoustic “cue” is sounded (III). The “run” is finished when the old target varnishes (IV). (b) The antisaccade task requires the subject to focus on the center position (I) until a new target (grey) presents randomly at either the right or the left eccentric position (II). The subject is immediately asked to shift the gaze to the contralateral half-plane (away from the target). The “run” is completed by shifting the gaze back onto the central position (III). Black dotted arrows illustrate the required gaze shift.
Figure 2
Figure 2
Visually guided horizontal reflexive saccade in a Parkinson's disease patient with mild cognitive impairment (PD-MCI) and a Parkinson's disease patient without cognitive impairment (PD), compared with an age-matched healthy control subject. Both PD patients presented with a considerable multistep sequence (saccadic hypometria) to shift their gaze onto the target (dashed-line). The videooculographically recorded data display the orthogonalized position for the cyclopean eye shown for the horizontal component (black lines). x-axis: acquisition time in seconds; y-axis: horizontal eye position in degrees.
Figure 3
Figure 3
Horizontal smooth pursuit eye movements (SPEM) elicited by a sinusoidal oscillating spot (f = 0.125 Hz) and exemplified for a Parkinson's disease patient (PD, upper panel) and a representative age-matched healthy control (lower panel). The PD patient presents with severely affected SPEM, frequently interrupted by anticipatory saccades. Although SPEM is heavily impaired in PD, patients retained the ability to perform episodes of genuine smooth pursuit (arrow). For recording details, see Figure 2.
Figure 4
Figure 4
Videooculographic recordings depicting an upward visually guided reflexive saccade elicited in a sudden target jump ranging from −15 to +15 degrees in a patient with progressive supranuclear palsy (PSP, left panel) compared with an age-matched healthy control (right panel). The PSP patient reaches the target (dashed line) in a pathological multistep pattern, approximately 2.5 seconds (x-axis) after new stimulus appearance (black line, vertical gaze position, and y-axis) whereas the control's gaze shift is accomplished after about 600 milliseconds. Abnormal horizontal square wave jerks (SWJ) manifest in the orthogonalized horizontal eye position (gray line in the left panel), together with vertical saccades indicating a curved trajectory. In contrast, the horizontal eye position in the control subject (gray line in the right panel) exhibits no alteration. The lower row shows the corresponding vertical eye velocity (y-axis) computed by use of sample-by-sample differences of the vertical eye position signal. The PSP patient (left) fails in generating larger saccades resulting in a reduced peak eye velocity (PEV) compared with the control subject.

References

    1. Goldberg ME, Walker MF. The control of gaze. In: Hudspeth AJ, Schwartz JH, Jessell TM, Siegelbaum SA, Kandel ER, editors. Principles of Neural Science. 5th edition. New York, NY, USA: McGraw-Hill; 2013. pp. 894–916.
    1. Leigh RJ, Zee DS. The Neurology of Eye Movements. 4th edition. New York, NY, USA: Oxford University Press; 2006.
    1. Anderson TJ, MacAskill MR. Eye movements in patients with neurodegenerative disorders. Nature Reviews Neurology. 2013;9(2):74–85.
    1. MacAskill MR, Graham CF, Pitcher TL, et al. The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson’s disease. Neuropsychologia. 2012;50(14):3338–3347.
    1. Pinkhardt EH, Kassubek J. Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism & Related Disorders. 2011;17(4):223–230.
    1. Terao Y, Fukuda H, Yugeta A, et al. Initiation and inhibitory control of saccades with the progression of Parkinson’s disease—changes in three major drives converging on the superior colliculus. Neuropsychologia. 2011;49(7):1794–1806.
    1. Klöppel S, Draganski B, Golding CV, et al. White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington’s disease. Brain. 2008;131, part 1:196–204.
    1. Neggers SF, Diepen RM, Zandbelt BB, Vink M, Mandl RC, Gutteling TP. A functional and structural investigation of the human fronto-basal volitional saccade network. PLoS ONE. 2012;7(1, article e29517)
    1. Gorges M, Müller HP, Lule D, Ludolph AC, Pinkhardt EH, Kassubek J. Functional connectivity within the default mode network is associated with saccadic accuracy in Parkinson’s disease: a resting-state FMRI and videooculographic study. Brain Connectivity. 2013;3(3):265–272.
    1. Raichle ME. Two views of brain function. Trends in Cognitive Sciences. 2010;14(4):180–190.
    1. Anderson CH, Essen DC, Olshausen BA. Directed visual attention and the dynamic control of information flow. In: Itti L, Rees G, Tsotsos J, editors. Encyclopedia of Visual Attention. Elsevier/Academic Press; 2004.
    1. Donaghy C, Thurtell MJ, Pioro EP, Gibson JM, Leigh RJ. Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. Journal of Neurology, Neurosurgery & Psychiatry. 2011;82(1):110–116.
    1. Garbutt S, Matlin A, Hellmuth J, et al. Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer’s disease. Brain. 2008;131, part 5:1268–1281.
    1. Kapoula Z, Yang Q, Otero-Millan J, et al. Distinctive features of microsaccades in Alzheimer’s disease and in mild cognitive impairment. Age. 2014;36(2):535–543.
    1. Walls GL. The evolutionary history of eye movements. Vision Research. 1962;2(1–4):69–80.
    1. Fukushima K, Fukushima J, Warabi T, Barnes GR. Cognitive processes involved in smooth pursuit eye movements: behavioral evidence, neural substrate and clinical correlation. Frontiers in Systems Neuroscience. 2013;7, article 4
    1. Becker W. The neurobiology of saccadic eye movements. Metrics. Reviews of Oculomotor Research. 1989;3:13–67.
    1. Martinez-Conde S, Otero-Millan J, Macknik SL. The impact of microsaccades on vision: towards a unified theory of saccadic function. Nature Reviews Neuroscience. 2013;14(2):83–96.
    1. Abadi RV, Gowen E. Characteristics of saccadic intrusions. Vision Research. 2004;44(23):2675–2690.
    1. Martinez-Conde S, Macknik SL, Hubel DH. The role of fixational eye movements in visual perception. Nature Reviews Neuroscience. 2004;5(3):229–240.
    1. Martinez-Conde S, Macknik SL, Troncoso XG, Dyar TA. Microsaccades counteract visual fading during fixation. Neuron. 2006;49(2):297–305.
    1. Otero-Millan J, Troncoso XG, Macknik SL, Serrano-Pedraza I, Martinez-Conde S. Saccades and microsaccades during visual fixation, exploration, and search: foundations for a common saccadic generator. Journal of Vision. 2008;8(14, article 21):1–18.
    1. Martinez-Conde S, Macknik SL, Troncoso XG, Hubel DH. Microsaccades: a neurophysiological analysis. Trends in Neurosciences. 2009;32(9):463–475.
    1. McCamy MB, Najafian Jazi A, Otero-Millan J, Macknik SL, Martinez-Conde S. The effects of fixation target size and luminance on microsaccades and square-wave jerks. PeerJ. 2013;1, article e9
    1. Otero-Millan J, Schneider R, Leigh RJ, Macknik SL, Martinez-Conde S. Saccades during attempted fixation in parkinsonian disorders and recessive ataxia: from microsaccades to square-wave jerks. PLoS ONE. 2013;8(3, article e58535)
    1. Kowler E, Martins AJ. Eye movements of preschool children. Science. 1982;215(4535):997–999.
    1. Rosini F, Federighi P, Pretegiani E, et al. Ocular-motor profile and effects of memantine in a familial form of adult cerebellar ataxia with slow saccades and square wave saccadic intrusions. PLoS ONE. 2013;8(7, article e69522)
    1. Chen AL, Riley DE, King SA, et al. The disturbance of gaze in progressive supranuclear palsy: implications for pathogenesis. Frontiers in Neurolog. 2010;1, article 147
    1. Kassubek J. Diagnostic procedures during the course of Parkinson’s disease. Basal Ganglia. 2014
    1. Zee DS. Ophthalmoscopy in examination of patients with vestibular disorders. Annals of Neurology. 1978;3(4):373–374.
    1. Serra A, Leigh RJ. Diagnostic value of nystagmus: spontaneous and induced ocular oscillations. Journal of Neurology, Neurosurgery & Psychiatry. 2002;73(6):615–618.
    1. Eggert T. Eye movement recordings: methods. Developments in Ophthalmology. 2007;40:15–34.
    1. Schneider E, Villgrattner T, Vockeroth J, et al. EyeSeeCam: an eye movement-driven head camera for the examination of natural visual exploration. Annals of the New York Academy of Sciences. 2009;1164:461–467.
    1. Kimmig H, Haussmann K, Mergner T, Lucking CH. What is pathological with gaze shift fragmentation in Parkinson’s disease? Journal of Neurology. 2002;249(6):683–692.
    1. Pinkhardt EH, Jürgens R, Lule D, et al. Eye movement impairments in Parkinson’s disease: possible role of extradopaminergic mechanisms. BMC Neurology. 2012;12, article 5
    1. Helmchen C, Pohlmann J, Trillenberg P, Lencer R, Graf J, Sprenger A. Role of anticipation and prediction in smooth pursuit eye movement control in Parkinson’s disease. Movement Disorders. 2012;27(8):1012–1018.
    1. Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jürgens R. Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease. Journal of Neurology. 2009;256(9):1438–1446.
    1. van den Heuvel MP, Hulshoff Pol HE. Exploring the brain network: a review on resting-state fMRI functional connectivity. European Neuropsychopharmacology. 2010;20(8):519–534.
    1. Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Parkinson’s disease: the non-motor issues. Parkinsonism & Related Disorders. 2011;17(10):717–723.
    1. Park A, Stacy M. Non-motor symptoms in Parkinson’s disease. Journal of Neurology. 2009;256(supplement 3):293–298.
    1. Braak H, del Tredici K. Neuroanatomy and Pathology of Sporadic Parkinson's Disease. Vol. 201. Berlin, Germany: Springer; 2009. (Advances in Anatomy, Embryology and Cell Biology).
    1. Braak H, del Tredici K, Rub U, de Vos RA, Steur ENJ, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging. 2003;24(2):197–211.
    1. Braak H, Müller CM, Rub U, et al. Pathology associated with sporadic Parkinson’s disease—where does it end? Journal of Neural Transmission. Supplement. 2006;(70):89–97.
    1. Braak H, Rub U, Jansen Steur EN, del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology. 2005;64(8):1404–1410.
    1. Machner B, Klein C, Sprenger A, et al. Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD. Neurology. 2010;75(2):125–128.
    1. Pinkhardt EH, Issa H, Gorges M, et al. Do eye movement impairments in patients with small vessel cerebrovascular disease depend on lesion load or on cognitive deficits? A video-oculographic and MRI study. Journal of Neurology. 2014;261(4):791–803.
    1. Munoz DP, Everling S. Look away: the anti-saccade task and the voluntary control of eye movement. Nature Reviews Neuroscience. 2004;5(3):218–228.
    1. Hikosaka O, Wurtz RH. The basal ganglia. Reviews of Oculomotor Research. 1989;3:257–281.
    1. Sauleau P, Pollak P, Krack P, et al. Subthalamic stimulation improves orienting gaze movements in Parkinson’s disease. Clinical Neurophysiology. 2008;119(8):1857–1863.
    1. Kheradmand A, Zee DS. Cerebellum and ocular motor control. Frontiers in Neurology. 2011;2, article 53
    1. van Stockum S, MacAskill MR, Myall D, Anderson TJ. A perceptual discrimination task results in greater facilitation of voluntary saccades in Parkinson’s disease patients. European Journal of Neuroscience. 2013;37(1):163–172.
    1. Ptak R, Muri RM. The parietal cortex and saccade planning: lessons from human lesion studies. Frontiers in Human Neuroscience. 2013;7, article 254
    1. Purcell BA, Weigand PK, Schall JD. Supplementary eye field during visual search: salience, cognitive control, and performance monitoring. The Journal of Neuroscience. 2012;32(30):10273–10285.
    1. Bosch SE, Neggers SF, van der Stigchel S. The role of the frontal eye fields in oculomotor competition: image-guided TMS enhances contralateral target selection. Cerebral Cortex. 2013;23(4):824–832.
    1. Yerram S, Glazman S, Bodis-Wollner I. Cortical control of saccades in Parkinson disease and essential tremor. Journal of Neural Transmission. 2013;120(1):145–156.
    1. Gaymard B, Rivaud S, Cassarini JF, et al. Effects of anterior cingulate cortex lesions on ocular saccades in humans. Experimental Brain Research. 1998;120(2):173–183.
    1. Mosimann UP, Muri RM, Burn DJ, Felblinger J, O’Brien JT, McKeith IG. Saccadic eye movement changes in Parkinson’s disease dementia and dementia with Lewy bodies. Brain. 2005;128, part 6:1267–1276.
    1. Okun MS. Deep-brain stimulation for Parkinson’s disease. The New England Journal of Medicine. 2013;368(5):483–484.
    1. Nilsson MH, Patel M, Rehncrona S, Magnusson M, Fransson PA. Subthalamic deep brain stimulation improves smooth pursuit and saccade performance in patients with Parkinson’s disease. Journal of NeuroEngineering and Rehabilitation. 2013;10, article 33
    1. Yugeta A, Terao Y, Fukuda H, et al. Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease. Neurology. 2010;74(9):743–748.
    1. Fahn S, Elton RL, UPDRS Development Committee . Recent Developments in Parkinson’s Disease. Florham Park, NJ, USA: Macmillian Healthcare Information; 1987. The unified Parkinson’s disease rating scale; pp. 153–163, 293–304.
    1. Hacker CD, Perlmutter JS, Criswell SR, Ances BM, Snyder AZ. Resting state functional connectivity of the striatum in Parkinson’s disease. Brain. 2012;135, part 12:3699–3711.
    1. Dubbelink KTO, Stoffers D, Deijen JB, Twisk JW, Stam CJ, Berendse HW. Cognitive decline in Parkinson’s disease is associated with slowing of resting-state brain activity: a longitudinal study. Neurobiology of Aging. 2013;34(2):408–418.
    1. Tessitore A, Esposito F, Vitale C, et al. Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology. 2012;79(23):2226–2232.
    1. Pinkhardt EH, Jürgens R, Becker W, Valdarno F, Ludolph AC, Kassubek J. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson’s syndrome, and idiopathic Parkinson’s disease. Journal of Neurology. 2008;255(12):1916–1925.
    1. Shaikh AG, Xu-Wilson M, Grill S, Zee DS. ‘Staircase” square-wave jerks in early Parkinson’s disease. British Journal of Ophthalmology. 2011;95(5):705–709.
    1. Blekher T, Weaver M, Rupp J, et al. Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism & Related Disorders. 2009;15(7):506–510.
    1. Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends in Neurosciences. 2011;34(11):581–590.
    1. Hasegawa T, Baba T, Kobayashi M, et al. Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy. Neurochemistry International. 2010;57(8):857–866.
    1. Anderson T, Luxon L, Quinn N, Daniel S, Marsden CD, Bronstein A. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Movement Disorders. 2008;23(7):977–984.
    1. Ludolph AC, Kassubek J, Landwehrmeyer BG, et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. European Journal of Neurology. 2009;16(3):297–309.
    1. Armstrong IT, Judson M, Munoz DP, Johansson RS, Flanagan JR. Waiting for a hand: saccadic reaction time increases in proportion to hand reaction time when reaching under a visuomotor reversal. Frontiers in Human Neuroscience. 2013;7, article 319
    1. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain. 2005;128, part 6(6):1247–1258.
    1. Williams DR, Litvan I. Parkinsonian syndromes. Continuum. 2013;19(5, Movement Disorders):1189–1212.
    1. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathology. 2007;17(1):74–82.
    1. Marx S, Respondek G, Stamelou M, et al. Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease. Frontiers in Behavioral Neuroscience. 2012;6, article 88
    1. Otero-Millan J, Macknik SL, Serra A, Leigh RJ, Martinez-Conde S. Triggering mechanisms in microsaccade and saccade generation: a novel proposal. Annals of the New York Academy of Sciences. 2011;1233(1):107–116.
    1. Hardwick A, Rucker JC, Cohen ML, et al. Evolution of oculomotor and clinical findings in autopsy-proven richardson syndrome. Neurology. 2009;73(24):2122–2124.
    1. Brown RG, Lacomblez L, Landwehrmeyer BG, et al. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. 2010;133(8):2382–2393.
    1. Walker FO. Huntington’s disease. The Lancet. 2007;369(9557):218–228.
    1. Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C. Oculomotor deficits indicate the progression of Huntington’s disease. Progress in Brain Research. 2008;171:555–558.
    1. Becker W, Jurgens R, Kassubek J, Ecker D, Kramer B, Landwehrmeyer B. Eye-head coordination in moderately affected Huntington’s disease patients: do head movements facilitate gaze shifts? Experimental Brain Research. 2009;192(1):97–112.
    1. Turner TH, Goldstein J, Hamilton JM, et al. Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington’s disease. Journal of Motor Behavior. 2011;43(4):295–302.
    1. Fielding J, Georgiou-Karistianis N, Bradshaw J, et al. Impaired modulation of the vestibulo-ocular reflex in Huntington’s disease. Movement Disorders. 2004;19(1):68–75.
    1. Blekher T, Johnson SA, Marshall J, et al. Saccades in presymptomatic and early stages of Huntington disease. Neurology. 2006;67(3):394–399.
    1. Fielding J, Georgiou-Karistianis N, White O. The role of the basal ganglia in the control of automatic visuospatial attention. Journal of the International Neuropsychological Society. 2006;12(5):657–667.
    1. Patel SS, Jankovic J, Hood AJ, Jeter CB, Sereno AB. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. Journal of the Neurological Sciences. 2012;313(1-2):35–41.
    1. Kassubek J, Pinkhardt EH. Neuro-ophthalmological alterations in patients with movement disorders. In: Gálvez-Jiménez N, Tuite P, editors. Uncommon Causes of Movement Disorders. 1st edition. Cambridge, UK: Cambridge University Press; 2011. pp. 306–315.
    1. Golding CV, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C. Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology. 2006;67(3):485–487.
    1. Dürr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. The Lancet Neurology. 2010;9(9):885–894.
    1. Velazquez-Perez L, Seifried C, Abele M, et al. Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2. Clinical Neurophysiology. 2009;120(3):632–635.
    1. Jamadar SD, Fielding J, Egan GF. Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Frontiers in Psychology. 2013;4, article 749:1–15.

Source: PubMed

3
Abonnere